Loperamide vs. Placebo's Effect on Ileostomy Output: A Clinical Randomized Blinded Cross-over Study

NCT02266849 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

12

Enrollment

OTHER

Sponsor class

Stopped Insuficcient recruiting

Conditions

Rectal Cancer
Ulcerative Colitis
Short Bowel Syndrome

Interventions

DRUG: Loperamide
DRUG: Placebo

Sponsor

Odense University Hospital